# Enterix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enterix

- Industry: Biotechnology
- Headquarters: Sydney, Australia
- Website: www.insuretest.com
- Total disclosed funding: $7.5M
- Latest round: Series A (Jul 26, 2001)
- Investors on record: 3

## About

Enterix is a healthcare company specializing in innovative fecal immunochemical tests (FIT) designed to improve colorectal cancer screening for individuals, particularly those aged 45 and older.Enterix is focused on developing accessible screening solutions for colorectal cancer. The company is headquartered in Sydney, Australia, and has undergone a pivotal change when it was acquired by Quest Diagnostics Incorporated for USD 44 mn on June 6, 2006. The CEO of Enterix is Michael Paris.Enterix specializes in its core product, InSure One, which is a unique Fecal Immunochemical Test (FIT) facilitating easy colorectal cancer screening. It allows users to collect samples with a brush in toilet water, enhancing comfort and privacy. The product targets individuals at average risk for colorectal cancer, especially those aged 45 and older, and serves a broad market of healthcare providers and patients in the United States.In 2011, Enterix reported a revenue of USD 2,050,192 and an EBITDA of USD 750,507.6, primarily generated through the direct sale of its fecal immunochemical test kits to healthcare providers and consumers.Following the acquisition by Quest Diagnostics, Enterix plans to leverage the resources to enhance product development and expand its market reach. While specific new products or geographic regions targeted for expansion have not been detailed, the strategic utilization of the recent funding is likely focused on improving service delivery and increasing accessibility for colorectal cancer screening across various healthcare platforms.

## Funding rounds

- Series A, Jul 26, 2001, $7.5M — Propel Funeral Partners, Macquarie Technology Ventures, Innovation Capital

## Investors

- Propel Funeral Partners (https://capitalatlas.ai/funds/propel-funeral-partners) — Series A
- Macquarie Technology Ventures (https://capitalatlas.ai/funds/macquarie-technology-ventures) — Series A
- Innovation Capital — Series A